Effect of Epsom salt Soak on Migraine among Nursing Students at SUM Nursing College, Bhubaneswar

By:

Radharani Rath and Anitha. B

Volume: 10 | Issue: 01 | Year 2024 | Subscription
International Journal of Neurological Nursing
Received Date: 01/04/2024
Acceptance Date: 03/23/2024
Published On: 2024-03-28
First Page:
Last Page:

Journal Menu

Citation:
Radharani Rath and Anitha. B Effect of Epsom salt Soak on Migraine among Nursing Students at SUM Nursing College, Bhubaneswar International Journal of Neurological Nursing. 2024; 10(01): -p.
Abstract

Background: Migraine, a genetically influenced disorder, manifests as recurring episodes of intense headache, typically on one side of the head and often accompanied by nausea, sensitivity to light and sound. It constitutes a significant source of chronic illness and is a leading contributor to various types of headaches globally. Epsom salt, known for its anti-inflammatory and pain-relieving properties, offers a side-effect-free option for alleviating migraine pain and serves as a readily available and affordable complementary alternative medicine for this condition. Aim: To assess the effect of Epsom salt soak on Migraine pain among B.Sc nursing students. Methods & Materials: A quasi-experimental design, specifically a non-randomized control group approach, was utilized for this study. The research involved 30 nursing students from SUM Nursing College, Bhubaneswar, selected through purposive sampling technique rather than random selection. Result: The findings revealed that post-test mean value (14+2.10) in experimental group with t test value =-2.20 and P value is 0.02 which was statistically significant difference in the experimental and control group at P ≤ 0.05. Conclusion: The results of this study indicated a noteworthy decrease in migraine occurrence among the students. Hence the administration of Epsom salt soak was effective in treating the migraine ailments.

Keywords: Effectiveness, Migraine, Epsom salt Soak, chronic illness, complementary alternative medicine.

Loading

Citation:

Radharani Rath and Anitha. B Effect of Epsom salt Soak on Migraine among Nursing Students at SUM Nursing College, Bhubaneswar International Journal of Neurological Nursing. 2024; 10(01): -p.

Refrences:

  1. Bigal ME, Bordini CA, Tepper SJ, Speciali JG. Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double- blind, placebo-controlled study. Cephalalgia. 2002 Jun 1;22(5):345-53.
  1. Wachholtz AB, Malone CD, Pargament KI. Effect of different meditation types on migraine headache medication use. Behavioral Medicine. 2017 Jan 2;43(1):1-8.
  2. Sankar L. Effectiveness of Epsom Salt with Hot Water Application on Knee Joint Pain among Elderly in a Selected Rural Area at Puducherry. Pon J Nurs 2019;12(2):42–45.
  3. Smith TR, Nicholson RA, Banks JW. Migraine education improves quality of life in a primary care setting. Headache. 2010 Apr;50(4):600-12. doi: 10.1111/j.1526-4610.2010.01618.x. Epub 2010 Feb 9. PMID: 20148982; PMCID: PMC2872510.
  4. Spierings EL, Donoghue S, Mian A, Wöber C. Sufficiency and necessity in migraine: how do we figure out if triggers are absolute or partial and, if partial, additive or potentiating?.Current pain and headache reports. 2014 Oct 1;18(10):1-7.
  5. Malone CD, Bhowmick A, Wachholtz AB. Migraine: treatments, comorbidities, and quality of life, in the USA.
  6. Houle TT, Butschek RA, Turner DP, Smitherman TA, Rains JC, Penzien DB. Stress and sleep duration predict headache severity in chronic headache sufferers. PAIN®. 2012 Dec 31;153(12):2432-40.
  1. Darabaneanu S, Overath CH, Rubin D, Lüthje S, Sye W, Niederberger U, Gerber WD, Weisser B. Aerobic exercise as a therapy option for migraine: a pilot study. International journal of sports medicine. 2011 Jun;32(06):455-60.
  2. Houle TT, Butschek RA, Turner DP, Smitherman TA, Rains JC, Penzien DB. Stress and sleep duration predict headache severity in chronic headache sufferers. PAIN®. 2012 Dec 31;153(12):2432-40
  3. Houle TT, Butschek RA, Turner DP, Smitherman TA, Rains JC, Penzien DB. Stress and sleep duration predict headache severity in chronic headache sufferers. PAIN®. 2012 Dec 31;153(12):2432-40. Abbas AM, Sakr HF. Effect of magnesium sulfate and thyroxine on inflammatory markers in a rat model of hypothyroidism. Canadian journal of physiology and pharmacology. 2015 Oct 9;94(4):426-32.
  4. Hirashima J, Yamana H, Matsui H, Fushimi K, Yasunaga H. Effect of intravenous magnesium sulfate on mortality in patients with severe acute asthma. Respirology. 2016 Feb 1.Lee YY, Yang YP, Huang PI, Li WC, Huang MC, Kao CL, Chen YJ, Chen MT. Exercise suppresses COX-2 pro-inflammatory pathway in vestibular migraine. Brain research bulletin. 2015 Jul 31;116:98-105.
  5. Rude RK, Singer FR. Magnesium deficiency and excess. Annual review of medicine. 1981 Feb;32(1):245-59.
  6. Bigal ME, Bordini CA, Speciali JG. Diclofenaco intramuscular no tratamento agudo da migrânea: um estudo duplo cego placebo controlado [Intramuscular diclofenac in the acute treatment of migraine: a double-blind placebo controlled study]. Arq Neuropsiquiatr. 2002 Jun;60(2-B):410-5. Portuguese. PMID: 12131942.
  7. Goadsby PJ, Zanchin G, Geraud G, de Klippel N, Diaz-Insa S, Gobel H, Cunha L, Ivanoff N, Falques M, Fortea J. Early vs. non-early intervention in acute migraine-‘Act when Mild (AwM)’. A double-blind, placebo-controlled trial of almotriptan. Cephalalgia. 2008 Apr;28(4):383-91. doi: 10.1111/j.1468-2982.2008.01546.x. Epub 2008 Feb 20. Erratum in: Cephalalgia. 2008 Jun;28(6):679. PMID: 18294251.
  8. Goadsby PJ. The ‘Act when Mild’ (AwM) study: a step forward in our understanding of early treatment in acute migraine. Cephalalgia. 2008 Sep;28 Suppl 2:36-41. doi: 10.1111/j.1468-2982.2008.01689.x. PMID: 18715331.
  9. Diener HC. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg. Curr Med Res Opin. 2005 Oct;21(10):1603-10. doi: 10.1185/030079905X65448. PMID: 16238900.
  10. Diener HC, Gendolla A, Gebert I, Beneke M. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial. Headache. 2005 Jul-Aug;45(7):874-82. doi: 10.1111/j.1526-4610.2005.05151.x. PMID: 15985104.
  11. Diamond ML, Cady RK, Mao L, Biondi DM, Finlayson G, Greenberg SJ, Wright P. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines. Headache. 2008 Feb;48(2):248-58. doi: 10.1111/j.1526-4610.2007.01019.x. PMID: 18234046.
  12. Freitag F, Smith T, Mathew N, Rupnow M, Greenberg S, Mao L, Finlayson G, Wright P, Biondi D; AEGIS Investigator Study Group. Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial. Headache. 2008 Mar;48(3):341-54. doi: 10.1111/j.1526-4610.2007.01044.x. PMID: 18302700.
  13. Dahlöf CG, Pascual J, Dodick DW, Dowson AJ. Efficacy, speed of action and tolerability of almotriptan in the acute treatment of migraine: pooled individual patient data from four randomized, double-blind, placebo-controlled clinical trials. Cephalalgia. 2006 Apr;26(4):400-8. doi: 10.1111/j.1468-2982.2005.01080.x. PMID: 16556240.